FDA Delays Rule on Generic Drug Labeling Amid Controversy

Tuesday, November 18, 2014

Source: MM&M

FDA is holding off on the release of a controversial rule that would allow generic drug makers to use the same process as brand-name drugs in updating safety information on product labels. A final ruling the FDA had previously announced would appear next month will now be published in the fall of 2015, The Wall Street Journal reports.

View All News »